Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic

Lourdes Ortiz-Fernández1, Francisco David Carmona2, Raquel López-Mejías3

  • 1Instituto de Parasitologia y Biomedicina Lopez-Neyra, Granada, Spain.

Insights

This study identified KDM4C as a new shared risk gene for systemic vasculitis, highlighting the role of epigenetics in these rare blood vessel diseases. Genetic analysis revealed a common susceptibility locus, advancing our understanding of vasculitis predisposition.

Area of Science:

  • Genetics
  • Immunology
  • Epigenetics

Background:

  • Systemic vasculitides are rare, complex blood vessel diseases with unknown causes.
  • Understanding the genetic factors contributing to vasculitis is crucial for developing effective treatments.

Purpose of the Study:

  • To identify shared genetic susceptibility loci across different types of systemic vasculitis.
  • To investigate the genetic component underlying predisposition to vasculitis.

Main Methods:

  • A cross-phenotype meta-analysis of Immunochip genotyping data from 2465 vasculitis patients and 4632 controls.
  • Analysis of genetic data from giant cell arteritis, Takayasu's arteritis, antineutrophil cytoplasmic antibody-associated vasculitis, and IgA vasculitis.
  • Interrogation of functional consequences of associated variants using public annotation data.

Main Results:

  • The strongest association signal was an intergenic polymorphism between HLA-DQB1 and HLA-DQA2 (rs6932517).
  • The KDM4C gene was identified as a common risk locus for vasculitides (rs16925200).
  • KDM4C encodes a histone demethylase involved in epigenetic gene regulation.

Conclusions:

  • KDM4C is identified as a novel shared risk gene for systemic vasculitides.
  • This finding supports the significant role of epigenetic mechanisms in the development of immune-mediated diseases.
  • The study provides insights into the genetic underpinnings of vasculitis.
Abstract

Related Concept Videos

Monohybrid Crosses01:20

Monohybrid Crosses

Overview
239.9K
Dihybrid Crosses01:18

Dihybrid Crosses

Overview
81.5K
Cross-Sectional Research01:50

Cross-Sectional Research

In cross-sectional research, a researcher compares multiple segments of the population at the same time. If they were interested in people's dietary habits, the researcher might directly compare different groups of people by age. Instead of following a group of people for 20 years to see how their dietary habits changed from decade to decade, the researcher would study a group of 20-year-old individuals and compare them to a group of 30-year-old individuals and a group of 40-year-old...
12.7K
Locus of Control01:26

Locus of Control

Locus of control describes how individuals perceive the causes of events in their lives, influencing motivation and well-being. Introduced by Julian Rotter in 1954, it is categorized into internal and external locus of control.Internal Locus of ControlIndividuals with an internal locus of control believe their actions determine outcomes, fostering responsibility, self-efficacy, and motivation. For example, an employee may attribute career success to hard work. Research links this mindset to...
240
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
172.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
821